HC Wainwright & Co. Maintains Buy on Immunocore Hldgs, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has maintained a Buy rating on Immunocore Holdings (IMCR) and increased the price target from $90 to $100.

May 09, 2024 | 5:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Immunocore Holdings and raises the price target from $90 to $100.
The increase in price target by a reputable analyst firm like HC Wainwright & Co. typically signals a strong bullish sentiment towards the company's future performance. This adjustment reflects positive expectations from the analyst, likely based on Immunocore Holdings' operational progress, financial health, or market position. Such endorsements can positively influence investor perception and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100